Background: People living with HIV/AIDS are at increased risk of developing malignancies- both AIDS defining and non-AIDS defining. The trends in incidence and severity of cancers among those with HIV/AIDS has greatly changed since the advent of ART. The aim of this study was to analyse the clinico-epidemiological profile of patients in South India with HIV/AIDS who subsequently developed malignancy. Methods: A retrospective study was conducted by reviewing the medical records of patients with HIV/AIDS who were diagnosed with cancer after seroconversion from January 2014 to December 2019 and presented to a tertiary medical centre. Results: Of the 627 cases of HIV presenting to the hospital during the study period, 50 (8%) developed cancer. Among the patients with cancer 14 (28%) had AIDS defining cancer while 36 (72%) had non- AIDS defining cancer. The mean CD4 cell count at the time of diagnosis with malignancy was 502.45/uL. Among the patients with AIDS defining malignancies, 10 patients (71.4%) had NHL, 3 patients (21.4%) had invasive cervical cancer and one patient (7.1%) was diagnosed with CNS lymphoma. Among the 36 cases of non-AIDS defining malignancies, there were 7 cases (19.4%) of malignancies of the upper airway (oral cavity, nasopharynx, larynx), 7 cases (19.4%) of malignancies of the female genital tract, 6 cases (16.7%) of haemato-lymphoid malignancies, 3 cases each (8.3%) of malignancies of the lung and GIT including anal canal. 2 cases each (5.6%) of breast carcinoma or carcinoma of the male genital tract. 1 case each (2.8%) of cancers of the eye, urinary tract and metastatic lesion with an unknown primary were also reported. Conclusion: Malignancies in HIV infected individuals in an emerging global health issue. In the present study, we report a prevalence of 8% of malignancies in HIV infected individuals and a higher incidence of non-AIDS defining malignancies.